1	Paciente	paciente	NCCS000	C0030705	persona	0-8	461_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	9-11	461_QUEST_clinical_caseMIR	SENT1	-	-
3	33	33		-	-	12-14	461_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	15-19	461_QUEST_clinical_caseMIR	SENT1	-	-
5	,	,	Fc	-	-	19-20	461_QUEST_clinical_caseMIR	SENT1	-	-
6	residente	residente	NCCS000	C0439848	calificador	21-30	461_QUEST_clinical_caseMIR	SENT1	-	-
7	en	en	SPS00	C1720294#C0332285	calificador#atributo	31-33	461_QUEST_clinical_caseMIR	SENT1	-	-
8	Valencia	valencia	NCFS000	-	-	34-42	461_QUEST_clinical_caseMIR	SENT1	-	-
9	,	,	Fc	-	-	42-43	461_QUEST_clinical_caseMIR	SENT1	-	-
10	que	que	CS	-	-	44-47	461_QUEST_clinical_caseMIR	SENT1	-	-
11	consulta	consultar	VMM02S0	C1704447_1	calificador_1	48-56	461_QUEST_clinical_caseMIR	SENT1	-	-
12	por	por	SPS00	C1704447_2	calificador_2	57-60	461_QUEST_clinical_caseMIR	SENT1	-	-
13	presentar	presentar	VMN0000	-	-	61-70	461_QUEST_clinical_caseMIR	SENT1	-	-
14	en	en	SPS00	C1720294#C0332285	calificador#atributo	71-73	461_QUEST_clinical_caseMIR	SENT1	-	-
15	la	el	DA0FS0	-	-	74-76	461_QUEST_clinical_caseMIR	SENT1	-	-
16	mejilla	mejilla	NCFS000	C1279153#C0007966	estructura_corporal	77-84	461_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
17	derecha	derecho	AQ0FS0	C0445291#C0445292#C0205090#C0450415	calificador	85-92	461_QUEST_clinical_caseMIR	SENT1	I-Estructura_Corporal	-
18	una	una		C0205447_1	calificador_1	93-96	461_QUEST_clinical_caseMIR	SENT1	-	-
19	placa	placa	NCFS000	C0332461	anomalía_morfológica	97-102	461_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
20	eritemato-anaranjada	eritemato-anaranjada	VMP00SF	-	-	103-123	461_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
21	tras	tras	SPS00	-	-	124-128	461_QUEST_clinical_caseMIR	SENT1	-	-
22	picadura	picadura	NCFS000	C0021564#C0079626_1	trastorno#anomalía_morfológica_1	129-137	461_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
23	de	de	SPS00	C0021564#C0079626_2	trastorno#anomalía_morfológica_2	138-140	461_QUEST_clinical_caseMIR	SENT1	-	-
24	insecto	insecto	NCMS000	C0021564#C0079626_3	trastorno#anomalía_morfológica_3	141-148	461_QUEST_clinical_caseMIR	SENT1	-	-
25	que	que	PR0CN000	-	-	149-152	461_QUEST_clinical_caseMIR	SENT1	-	-
26	ha	haber	VAIP3S0	-	-	153-155	461_QUEST_clinical_caseMIR	SENT1	-	-
27	ido	ir	VMP00SM	-	-	156-159	461_QUEST_clinical_caseMIR	SENT1	-	-
28	creciendo	crecer	VMG0000	-	-	160-169	461_QUEST_clinical_caseMIR	SENT1	-	-
29	lentamente	lentamente	RG	C0439834	calificador	170-180	461_QUEST_clinical_caseMIR	SENT1	-	-
30	hasta	hasta	SPS00	-	-	181-186	461_QUEST_clinical_caseMIR	SENT1	-	-
31	alcanzar	alcanzar	VMN0000	-	-	187-195	461_QUEST_clinical_caseMIR	SENT1	-	-
32	1,5	1.5	Z	-	-	196-199	461_QUEST_clinical_caseMIR	SENT1	-	-
33	cm	cm	NCMN000	-	-	200-202	461_QUEST_clinical_caseMIR	SENT1	-	-
34	y	y	CC	C1706368	calificador	203-204	461_QUEST_clinical_caseMIR	SENT1	-	-
35	que	que	CS	-	-	205-208	461_QUEST_clinical_caseMIR	SENT1	-	-
36	en	en	SPS00	C1720294#C0332285	calificador#atributo	209-211	461_QUEST_clinical_caseMIR	SENT1	-	-
37	las	el	DA0FP0	-	-	212-215	461_QUEST_clinical_caseMIR	SENT1	-	-
38	últimas	último	AO0FP0	-	-	216-223	461_QUEST_clinical_caseMIR	SENT1	-	-
39	semanas	semana	NCFP000	C0439230	calificador	224-231	461_QUEST_clinical_caseMIR	SENT1	-	-
40	se	se	P00CN000	-	-	232-234	461_QUEST_clinical_caseMIR	SENT1	-	-
41	ha	haber	VAIP3S0	-	-	235-237	461_QUEST_clinical_caseMIR	SENT1	-	-
42	ulcerado	ulcerar	VMP00SM	-	-	238-246	461_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
43	y	y	CC	C1706368	calificador	247-248	461_QUEST_clinical_caseMIR	SENT1	-	-
44	cubierto	cubrir	VMP00SM	-	-	249-257	461_QUEST_clinical_caseMIR	SENT1	-	-
45	de	de	SPS00	C0332285	atributo	258-260	461_QUEST_clinical_caseMIR	SENT1	-	-
46	una	una		C0205447_1	calificador_1	261-264	461_QUEST_clinical_caseMIR	SENT1	-	-
47	escamocostra	escamocostra	NCFS000	-	-	265-277	461_QUEST_clinical_caseMIR	SENT1	-	-
48	.	.	Fp	-	-	277-278	461_QUEST_clinical_caseMIR	SENT1	-	-

1	La	el	DA0FS0	-	-	279-281	461_QUEST_clinical_caseMIR	SENT2	-	-
2	lesión	lesión	NCFS000	C0332447#C1313971#C0221198	anomalía_morfológica	282-288	461_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
3	solo	solo	AQ0MS0	C0205171	calificador	289-293	461_QUEST_clinical_caseMIR	SENT2	-	-
4	le	le	PP3CSD00	C1292157#C0409974	hallazgo#trastorno	294-296	461_QUEST_clinical_caseMIR	SENT2	-	-
5	origina	originar	VMIP3S0	-	-	297-304	461_QUEST_clinical_caseMIR	SENT2	-	-
6	discretas	discreto	AQ0FP0	-	-	305-314	461_QUEST_clinical_caseMIR	SENT2	-	-
7	molestias	molestia	NCFP000	C0231218	hallazgo	315-324	461_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
8	si	si	CS	-	-	325-327	461_QUEST_clinical_caseMIR	SENT2	-	-
9	se	sin_especificar	NC00YL0	C0424374_1	hallazgo_1	328-330	461_QUEST_clinical_caseMIR	SENT2	-	-
10	rasca	rascar	VMM02S0	C0424374_2	hallazgo_2	331-336	461_QUEST_clinical_caseMIR	SENT2	-	-
11	.	.	Fp	-	-	336-337	461_QUEST_clinical_caseMIR	SENT2	-	-

1	Entre	entre	SPS00	C0205103	calificador	338-343	461_QUEST_clinical_caseMIR	SENT3	-	-
2	sus	su	DP3CP0	-	-	344-347	461_QUEST_clinical_caseMIR	SENT3	-	-
3	antecedentes	antecedente	NCMP000	-	-	348-360	461_QUEST_clinical_caseMIR	SENT3	-	-
4	destaca	destacar	VMIP3S0	-	-	361-368	461_QUEST_clinical_caseMIR	SENT3	-	-
5	psoriasis	psoriasis	NCFN000	C0033860	trastorno	369-378	461_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
6	en	en	SPS00	C1720294#C0332285	calificador#atributo	379-381	461_QUEST_clinical_caseMIR	SENT3	-	-
7	placas	placa	NCFP000	C0332461	anomalía_morfológica	382-388	461_QUEST_clinical_caseMIR	SENT3	-	-
8	en	en	SPS00	C1720294#C0332285	calificador#atributo	389-391	461_QUEST_clinical_caseMIR	SENT3	-	-
9	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	392-403	461_QUEST_clinical_caseMIR	SENT3	-	-
10	con	con	SPS00	C0332287	atributo	404-407	461_QUEST_clinical_caseMIR	SENT3	-	-
11	adalimumab	adalimumab	NC00SC0	C1122087	producto#sustancia	408-418	461_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
12	subcutáneo	subcutáneo	AQ0MS0	C0443315	calificador	419-429	461_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
13	.	.	Fp	-	-	429-430	461_QUEST_clinical_caseMIR	SENT3	-	-

1	Tiene	tener	VMIP3S0	-	-	431-436	461_QUEST_clinical_caseMIR	SENT4	-	-
2	buen	bueno	AQ0MS0	C0205170	calificador	437-441	461_QUEST_clinical_caseMIR	SENT4	-	-
3	estado	estado	NCMS000	C0449438#C1301808	atributo#medio_ambiente	442-448	461_QUEST_clinical_caseMIR	SENT4	-	-
4	general	general	AQ0CS0	C0205246	calificador	449-456	461_QUEST_clinical_caseMIR	SENT4	-	-
5	y	y	CC	C1706368	calificador	457-458	461_QUEST_clinical_caseMIR	SENT4	-	-
6	no	no	RN	C1298908	calificador	459-461	461_QUEST_clinical_caseMIR	SENT4	-	-
7	toma	tomar	VMIP3S0	C1515187	calificador	462-466	461_QUEST_clinical_caseMIR	SENT4	-	-
8	otros	otro	DI0MP0	C0205394#C0449210	calificador#estructura_corporal	467-472	461_QUEST_clinical_caseMIR	SENT4	-	-
9	fármacos	fármaco	NCMP000	C0013227	sustancia	473-481	461_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
10	ni	ni	CC	-	-	482-484	461_QUEST_clinical_caseMIR	SENT4	-	-
11	refiere	referir	VMIP3S0	-	-	485-492	461_QUEST_clinical_caseMIR	SENT4	-	-
12	alergias	alergia	NCFP000	C0020517	trastorno	493-501	461_QUEST_clinical_caseMIR	SENT4	B-Alergia	Negacion
13	a	a	SPS00	-	-	502-503	461_QUEST_clinical_caseMIR	SENT4	-	-
14	medicamentos	medicamento	NCMP000	C0456386#C0013227	atributo#sustancia	504-516	461_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
15	.	.	Fp	-	-	516-517	461_QUEST_clinical_caseMIR	SENT4	-	-

1	Indique	indicar	VMM03S0	-	-	518-525	461_QUEST_clinical_caseMIR	SENT5	-	-
2	el	el	DA0MS0	-	-	526-528	461_QUEST_clinical_caseMIR	SENT5	-	-
3	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	529-540	461_QUEST_clinical_caseMIR	SENT5	-	-
4	que	que	PR0CN000	-	-	541-544	461_QUEST_clinical_caseMIR	SENT5	-	-
5	emplearía	emplear	VMIC3S0	-	-	545-554	461_QUEST_clinical_caseMIR	SENT5	-	-
6	:	:	Fd	-	-	554-555	461_QUEST_clinical_caseMIR	SENT5	-	-
7	.	.	Fp	-	-	555-556	461_QUEST_clinical_caseMIR	SENT5	-	-

